HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 49 filers reported holding HARPOON THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $63 | -4.5% | 89 | 0.0% | 0.00% | – |
| Q1 2023 | $66 | +1.5% | 89 | 0.0% | 0.00% | – |
| Q4 2022 | $65 | – | 89 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 89 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 89 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 89 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 89 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | -80.0% | 89 | -73.1% | 0.00% | – |
| Q2 2021 | $5,000 | -54.5% | 331 | -34.5% | 0.00% | – |
| Q1 2021 | $11,000 | -60.7% | 505 | -70.4% | 0.00% | – |
| Q4 2020 | $28,000 | +40.0% | 1,705 | +42.1% | 0.00% | – |
| Q3 2020 | $20,000 | +81.8% | 1,200 | +82.1% | 0.00% | – |
| Q2 2020 | $11,000 | +57.1% | 659 | +9.8% | 0.00% | – |
| Q1 2020 | $7,000 | +75.0% | 600 | +100.0% | 0.00% | – |
| Q4 2019 | $4,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q3 2019 | $4,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,524,425 | $66,916,000 | 29.45% |
| MPM BioImpact LLC | 3,898,422 | $57,658,000 | 20.43% |
| New Leaf Venture Partners, L.L.C. | 2,921,405 | $43,208,000 | 9.39% |
| Soleus Capital Management, L.P. | 123,200 | $1,822,000 | 1.76% |
| EcoR1 Capital, LLC | 908,547 | $13,437,000 | 1.21% |
| Orbimed Advisors | 2,446,409 | $36,182,000 | 0.52% |
| Artal Group S.A. | 850,000 | $12,572,000 | 0.49% |
| SPHERA FUNDS MANAGEMENT LTD. | 384,031 | $5,680,000 | 0.47% |
| Cormorant Asset Management, LP | 649,994 | $9,613,000 | 0.38% |
| Fosun International Ltd | 190,483 | $2,817,000 | 0.23% |